October 03, 2014
The Federal Circuit will hear arguments Monday in a case that may clarify whether the U.S. Supreme Court's decision that Myriad Genetics Inc. cannot patent human genes invalidates other inventions involving natural products, as Myriad appeals the denial of an injunction in a case over its cancer-testing patents.
June 11, 2014
The American Civil Liberties Union and other groups that successfully invalidated Myriad Genetics Inc.'s isolated DNA patents in a U.S. Supreme Court case last year, urged the Federal Circuit on Monday to reject Myriad's bid to ban sales of cancer tests based on different patents.
April 14, 2014
Myriad Genetics Inc.'s fight to block the sales of Ambry Genetics Corp.'s cancer-testing products and defend a slew of its patents that were at the center of a high-profile U.S. Supreme Court ruling last year will have to wait its turn, the Federal Circuit ruled Monday.